| Literature DB >> 21808655 |
Zhihong Lin1, Jie Gu, Jin Xiu, Tingyan Mi, Jie Dong, Jyoti Kumar Tiwari.
Abstract
Traditional Chinese Medicine (TCM) has a 3000 years' history of human use. A literature survey addressing traditional evidence from human studies was done, with key result that top 10 TCM herb ingredients including Poria cocos, Radix polygalae, Radix glycyrrhizae, Radix angelica sinensis, and Radix rehmanniae were prioritized for highest potential benefit to dementia intervention, related to the highest frequency of use in 236 formulae collected from 29 ancient Pharmacopoeias, ancient formula books, or historical archives on ancient renowned TCM doctors, over the past 10 centuries. Based on the history of use, there was strong clinical support that Radix polygalae is memory improving. Pharmacological investigation also indicated that all the five ingredients mentioned above can elicit memory-improving effects in vivo and in vitro via multiple mechanisms of action, covering estrogen-like, cholinergic, antioxidant, anti-inflammatory, antiapoptotic, neurogenetic, and anti-Aβ activities. Furthermore, 11 active principles were identified, including sinapic acid, tenuifolin, isoliquiritigenin, liquiritigenin, glabridin, ferulic acid, Z-ligustilide, N-methyl-beta-carboline-3-carboxamide, coniferyl ferulate and 11-angeloylsenkyunolide F, and catalpol. It can be concluded that TCM has a potential for complementary and alternative role in treating senile dementia. The scientific evidence is being continuously mined to back up the traditional medical wisdom.Entities:
Year: 2011 PMID: 21808655 PMCID: PMC3144670 DOI: 10.1155/2012/692621
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
TCM formulae selected from ancient Chinese documents.
| Classification | Book name | Dynasty | Formulae amount |
|---|---|---|---|
| Pharmacopoeia |
| Song (10–13 century) | 45 |
|
| Song (10–13 century) | 2 | |
|
| Song (10–13 century) | 2 | |
|
| Ming (14–17 century) | 2 | |
|
| Ming (14–17 century) | 2 | |
|
| Qing (17–19 century) | 9 | |
|
| |||
| Formulae monographs |
| Jin (3-4 century) | 1 |
|
| Tang (7–10 century) | 3 | |
|
| Song (10–13 century) | 3 | |
|
| Song (10–13 century) | 1 | |
|
| Song (10–13 century) | 5 | |
|
| Yuan (13-14 century) | 4 | |
|
| Ming (14–17 century) | 29 | |
|
| Ming (14–17 century) | 1 | |
|
| Ming (14–17 century) | 1 | |
|
| Qing (17–19 century) | 1 | |
|
| Qing (17–19 century) | 4 | |
|
| |||
| Medical edition |
| Song (10–13 century) | 13 |
|
| Song (10–13 century) | 9 | |
|
| Yuan (13-14 century) | 4 | |
|
| Ming (14–17 century) | 21 | |
|
| Ming (14–17 century) | 21 | |
|
| Ming (14–17 century) | 2 | |
|
| Qing (17–19 century) | 16 | |
|
| Qing (17–19 century) | 16 | |
|
| Qing (17–19 century) | 2 | |
|
| Modern (20 century) | 7 | |
|
| |||
| Sum | 236 | ||
Top 10 memory-improving TCM herbs.
| Chi name | English name | Latin name | Part | Plant | Frequency |
|---|---|---|---|---|---|
| Fu Ling | Poria |
| Sclerotium |
| 182 |
| Ren Shen | Ginseng |
| Root, stem |
| 169 |
| Yuan Zhi | Thinleaf milkwort |
| Root |
| 139 |
| Gan Cao | Licorice |
| Root, stem |
| 100 |
| Dang Gui | Chinese Angelica |
| Root |
| 84 |
| Shi Chang Pu | Grassleaf sweelflag rhizome |
| Stem |
| 80 |
| Suan Zao Ren | Spina date seed |
| Seed |
| 79 |
| Shu Di Huang | Prepared rehmannia root |
| Root |
| 62 |
| Mai Dong | Dwarf lilyturf tuber |
| Root |
| 62 |
| Sheng Jiang | Fresh ginger |
| Stem |
| 53 |
(Note: data are cited from Pharmacopoeia of PR China 2005).
Memory-improving and neuro-protective effects of Poria cocos.
| Test | Test materials/dose | Test model | Endpoints/biomarkers | Effects | Reference |
|---|---|---|---|---|---|
|
| Extracts 20–100 mg/kg | Scopolamine-treated rats | Eight-arm radial maze | Improve spatial memory | [ |
| Extracts 250–500 mg/kg | Innate rats | Electro-physiology Spike amplitude | Enhance hippocampal LTP | [ | |
| Methanol extracts 200 mg/mL | Ellman ChE | ChE activity | Inhibit ChE by 27.8% | [ | |
| Aqueous extracts 0.2 mg/mL | Innate ICR mice | AChE activity | Inhibit AChE by 13.9% | [ | |
|
| |||||
|
| Aqueous extracts 31–250 | Brain neurons–neonatal rats | Cytosolic [Ca2+] i | Regulate bi-directly [Ca2+] i | [ |
Long-term potentiation (LTP); choline esterase (ChE); acetylcholinesterase (AChE).
Figure 1Chemical structures of sinapic acid and tenuifolin.
Memory-improving and neuro-protective effects of Radix et rhizoma glycyrrhizae.
| Test | Test materials /dose | Test model | Endpoint/biomarkers | Effects | Mechanisms | Reference |
|---|---|---|---|---|---|---|
|
| Extracts 75–300 mg/kg, 7d diet 0.5 or 1%, 6w | Diazepam treated mice | Elevated plus-maze test | Improve memory | Cholinergic | [ |
| Scopolamine treated mice | passive avoidance test | [ | ||||
| A | passive avoidance testMorris water-maze test TBARS/Catalase/AChE | Improve memory | Quench oxidative stress Inhibit AChE | [ | ||
| Aqueous extracts 150 mg/kg, 7d n-hexane extracts 5 mg/kg, 3d | Innate mice | AChE | Inhibit AChE | N.A. | [ | |
| Methanol extract 50–100 mg/kg, 21d | IR treated Mongolian gerbils | Cu, Zn-SOD1CA1 pyramidal cells | Protect neurons | Restore Cu, Zn-SOD1 | [ | |
| Liquiritigenin 2.3–21 mg/kg, 7d | A | Morris water maze testReference memory taskProbe taskTwo-way shuttle avoidance taskMAP, Nissle, Notch-2 | [ | |||
|
| ||||||
|
| Isoliquiritigenin 5–20 mg/kg, 7d | MCAO-treated rats | MDASOD,GSH-Px, CatalaseNa+-K+-ATPase, ATPEnergy charge, total adenine nucleotides | Protect brain | Promote energy metabolismInhibit oxidative stress | [ |
| Glabridin 1–4 mg/kg, 3d | Innate Mice | ChE | Improve memory | Inhibit ChE | [ | |
| Glabridin 5–25 mg/kg | IR-treated rats Staurosporine-treated neurons | MDA, GSH and SODBax, caspase-3,bcl-2 | Protect neurons | Inhibit apoptosisInhibit oxidative stress | [ | |
Acetylcholinesterase (AChE); cholinesterase (ChE); thiobarbituric acid-reactive substances (TBARS); superoxide dismutase (SOD); malondialdehyde (MDA); glutathione (GSH); microtubule-associated protein (MAP) 2; middle cerebral artery occlusion (MCAO); β amyloid (Aβ); Ischemia-reperfusion (IR); not available (N.A.).
Figure 2Chemical structures of isoliquiritigenin, liquiritigenin, and glabridin.
Figure 3Chemical structures of ferulic acid, Z-ligustilide, N-methyl-beta-carboline-3-carboxamide, coniferyl ferulate, and 11-angeloylsenkyunolide F.
Memory-improving and neuro-protective effects of Radix rehmanniae.
| Test | Test materials/dose | Test model | Endpoint/biomarkers | Effects | Mechanisms | Reference |
|---|---|---|---|---|---|---|
|
| Extracts 4.5–9.0 g/kg | MSG-treated rats | Morris maze test Step-down test c-fos, NGF expression | Improve memory | Motivate hippocampal c-fos /NGF expression | [ |
| Extracts 4.5–9.0 g/kg | MSG-treated rats | Morris maze test Step-down test NMDA-R1, GABA-R Glutamine, GABA levels | Improve memory | Motivate hippocampal NMDA-R1/GABA-R expression adjust Glutamine/GABA levels | [ | |
|
| ||||||
|
| Extracts 0.1–1.0 mg/mL, 1–3 d | C6 glioblastoma cells | GDNF gene expression | Stimulate GDNF expression | Up-regulate cPKC/ERK1/2 pathways | [ |
|
| ||||||
|
| Catalpol i.p., 10 mg/kg, 10 d | LPS-treated mice | MMPNF- | Improve memoryInhibit inflammation | Inhibit NF- | [ |
| Catalpol 2.5–10 mg/kg, 2 w | D-galactose-treated mice | Passive avoidance test LDH, GSH-ST, GS, CK | Improve memory | Inhibit oxidative stress Maintain energy metabolism | [ | |
| Catalpol i.p., 1–10 mg/kg | IR-treated Gerbils | Bcl-2, Bax, NO | Protect CA1 neuronsImprove memory | Inhibit apoptosis Inhibit oxidative stress | [ | |
| Catalpol i.p., 5 mg/kg, 10 d | Aged rats | GAP-43/synaptophysin PKC, BDNF | Protect neuroplasticity | Up-regulate PKC and BDNF (hippocampus) | [ | |
|
| ||||||
|
| Catalpol 0.5 mM, 1 h | MPTP-treated neurons | Cells Viability, MAO-B, ROS, MCI, MMP, MPT | Protect neurons | Protect mitochondriaMaintain MAO-B activity | [ |
| Catalpol 0.5 mM, 30 min | A | Cells Viability TNF- | Protect neurons | Inhibit inflammation | [ | |
| Catalpol 0.25–5 mg/ml | Primary rat cortical neurons | Cells Viability NF-200 antigen | Enhance axonal growthNo impact on survival | N.A. | [ | |
| Catalpol 0.1–100 | OGD-treated PC12 cells | Bcl-2, caspase-3/MMP SOD, GSH-Px | Inhibit apoptosis | Retain Bcl-2 and MMP suppress caspase-3 activation maintain SOD and GSH-Px | [ | |
| Catalpol 0.1–1.0 mM | H2O2-treated PC12 cells | Bcl-2 cytochrome c caspase | Protect neuronsInhibit apoptosis | Prevent cytochrome c release Inactivate caspase cascade | [ | |
| Catalpol 0.05–0.5 mM | H2O2-treated astrocytes | Cells Viability ROS | Inhibit oxidative stress | maintain glutathione Scavenge ROS | [ | |
| Catalpol 0.3–275.9 | OGD-treated mice astrocytes | Cell survival/MMP ROS, NO, iNOS, MDASOD, GSH-Px, GSH | Protect astrocytes | Inhibit oxidative stress | [ | |
Nerve growth factor (NGF); oxygen-glucose deprivation (OGD); lactate dehydrogenase (LDH); glutathione S-transferase (GSH-ST); glutamine synthetase (GS); creatine kinase (CK); mitochondrial complex I (MCI); mitochondrial membrain potential (MMP); mitochondrial permeability transition (MPT); brain-derived neurotrophic factor (BDNF); γ-amiobutyic acid (GABA); lactate dehydrogenase (LDH); nitric oxide (NO); inducible nitric oxide synthase (iNOS); nuclear factor-kappa B (NF-κB); protein kinase C (PKC); 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); monosodium glutamate (MSG); lipopolysaccharide (LPS); ischemia-reperfusion (IR); monoamine oxidase (MAO); tumour necrosis factor (TNF)-α; reactive oxygen species (ROS); superoxide dismutase (SOD); malondialdehyde (MDA); glutathione (GSH); glutathione peroxidase (GSH-Px); glial cell-derived neurotrophic factor (GDNF).
Figure 4Chemical structure of catalpol.
(a) Memory-improving and neuro-protective effects of Radix polygalae
| Test | Test materials/dose | Test model | Endpoint/biomarkers | Effects | Mechanisms | Reference |
|---|---|---|---|---|---|---|
| Clinic | Extracts 300 mg/d, 4 w | Healthy Korean elderly with subjective memory impairment and mild cognitive impairmentdouble-blind, placebo-controlled, randomized, parallel study | Korean version of California verbal learning testSelf-ordered pointing test | Improve verbal memory No adverse events, except mild dyspepsia | N.A. | [ |
|
| ||||||
|
| Extracts i.p., 2 mg/kg | Innate rats | Nestin/BrdU Tuj1/BrdU | Improve memory Promote neuro-genesis | Promote proliferation Promote neurite outgrowth | [ |
| Extracts | Stress-treated rats | Glucose utilization Cell adhesion molecule | Improve memory | Increase glucose utilization Increase total NCAM | [ | |
| Extracts 2 g/kg, 1–3 w | NBM-lesioning rats | Neurological test Step-through test | Improve memory | N.A. | [ | |
| Extracts i.p., 10 mg/kg | Scopolamine-treated rats | Passive avoidance test water maze test AChE | Improve memory | Inhibit AChE | [ | |
|
| ||||||
|
| Extracts 0.5–5 | Rat primary neurons exposed to Glutamate or A | Cell viability | Protect neurons | N.A. | [ |
| Extracts 0.05–5 | Rat cerebellar granule neurons exposed to NMDA | Glutamate release (Ca2+)i/ROS | Protect neurons | N.A. | [ | |
| Extracts 0.1–100 | Rat cortical neurons exposed to A | Axonal length Neuro-filament-H/MAP-2Cell viability | Activate axonal extension Protect neurons | N.A. | [ | |
Acetylcholinesterase (AChE); bromodeoxyuridine (BrdU); microtubule-associated protein-2 (MAP-2); nucleus basalis magnocellularis (NBM); neural cell adhesion molecule (NCAM); N-methyl-D-aspartic acid (NMDA); reactive oxygen species (ROS); β amyloid (Aβ); not available (N.A.); intraperitoneally (ip.).
(b) Memory-improving and neuro-protective effects of active components from Radix polygalae
| Test | Test materials/dose | Test model | Endpoints/biomarkers | Effects | Mechanisms | Reference |
|---|---|---|---|---|---|---|
|
| Sinapic acid 10–100 mg/kg | Scopolamine-treated rats | Radial maze test | Improve memory | N.A. | [ |
| Sinapic acid 3–100 mg/kg, 1 h | Scopolamine-treat mice Basal forebrain lesioning mice | Step-through test Ach/ChAT | Improve memory | N.A. | [ | |
| Tenuifolin 20–80 mg/kg, 15 d | Aged mice Dysmnesia mice | Step-down test Y maze trial AChE,NE,DA,5-HT | Improve memory | Increase NE and DA Inhibit AChE | [ | |
| Tenuigenin 18.5–74 mg/kg | A | Step-through test AchE, ChAT | Improve memory | Cholinergic | [ | |
| Acylated oligosaccharides1–10 mg/kg | Scopolamine-treated rats | Step-through test | Improve memory | Cholinergic | [ | |
|
| ||||||
|
| Tenuigenin 1–4 | APP-transfected SH-SY5Y cells | Fluorescence resonance energy transfer | Inhibit A | Inhibit BACE1 | [ |
| Onjisaponin 10 | Serum deficiency or glutamate-treated PC12 cells | Cell survival | Protect PC 12 cells | N.A. | [ | |
Acetylcholine (Ach); acetylcholinesterase (AChE); choline acetyltransferase (ChAT); 5-hydroxytryptamine (5-HT); dopamine (DA); norepinephrine (NE); beta-site APP cleaving enzyme (BACE); amyloid precursor protein (APP); β amyloid (Aβ); not available (N.A.).
(a) Memory-improving and neuro-protective effects of Radix Angelica sinensis
| Test | Test materials/dose | Test model | Endpoint/biomarkers | Effects | Mechanisms | Reference |
|---|---|---|---|---|---|---|
|
| Extracts 1 g/kg | scopolamine-treated rats cycloheximide-treated rats | Step-through test | Improve memory | N.A. | [ |
|
| Extracts 25–200 | A | MTT assay/Δ | Protect neurons | Quench oxidative stress | [ |
3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT); Lipid peroxidation (LPO); mitochondrial transmembrane potential (ΔΨm); β amyloid (Aβ); glutathione (GSH); not available (N.A.).
(b) Memory-improving and neuro-protective effects of active components from Radix Angelica sinensis
| Test | Test materials/dose | Test model | Endpoint/biomarkers | Effects | Mechanisms | Reference |
|---|---|---|---|---|---|---|
|
| Ferulic acid s.c., 5 mg/kg/d, 6 d | dl-buthionine-(S,R)-Sulfoximine treated mice | Object recognition test Oxidative carbonyl protein | Improve memory | Elevate carbonyl protein | [ |
| Ferulic acid 28 d | Trimethyltin-treated mice | Y-maze testPassive avoidance testChAT | Improve memory | Activate ChAT | [ | |
| Ferulic acid i.p., 20–80 mg/kg, 3 d | Glutamate-treated mice | Behavioral test histopathology [(3)H]-labeled glutamate bcl-2/caspase-3 | Protect brain | NMDA receptor antagonist | [ | |
| Ferulic acid 0.006%, 4 w | A | Step-through test Y-maze test Water maze test GFAP/IL-1 | Improve memoryProtect brain | Suppress astrocytes immunoreactivities | [ | |
| Ferulic acid 50–100 mg/kg | Scopolamine-treated rats Cycloheximide-treated rats | Step-through test | Improve memory | Cholinergic Enhance CBF | [ | |
| Z-ligustilide 10–40 mg/kg, 4 w | CCAO-treated rats | Morris water maze Neurons/astrocytes count MDA/SOD/ChAT/AChE | Improve memory | Inhibit oxidative stress Cholinergic | [ | |
| Z-ligustilide 20–80 mg/kg | MCAO-treated rats | TTC staining Brain swelling Behavioural score | Protect brain | N.A. | [ | |
| Z-ligustilide 5–20 mg/kg | IR-treated ICR mice | TTC staining MDA/GSH-Px/SOD Bcl-2/Bax/caspase-3 | Protect brain | Inhibit oxidative stress Inhibit apoptosis | [ |
Choline acetyltransferase (ChAT); cerebral blood flow (CBF); glial fibrillary acidic protein (GFAP); interleukin-1 (IL-1); glutathione peroxidase (GSH-PX); 2,3,5-triphenyltetrazolium chloride (TTC); subcutaneously (s.c.); ischemia-reperfusion (IR); superoxide dismutase (SOD); malondialdehyde (MDA); acetylcholinesterase (AChE); common carotid arteries occlusion (CCAO); middle cerebral artery occlusion (MCAO); β amyloid (Aβ); N-methyl-D-aspartate (NMDA); not available (N.A.).